Objective: To investigate the efficacy of magnesium-strontium co-doped hydroxyapatite mineralized collagen (MSHA/Col) in improving the bone repair microenvironment and enhancing bone regeneration capacity, providing a strategy to address the insufficient biomimetic composition and limited bioactivity of traditional hydroxyapatite mineralized collagen (HA/Col) scaffolds. Methods: A high-molecular-weight polyacrylic acid-stabilized amorphous calcium magnesium strontium phosphate precursor (HPAA/ACMSP) was prepared. Its morphology and elemental distribution were characterized by high-resolution transmission electron microscopy (TEM) and energy-dispersive spectroscopy. Recombinant collagen sponge blocks were immersed in the HPAA/ACMSP mineralization solution. Magnesium-strontium co-doped hydroxyapatite was induced to deposit within collagen fibers (experimental group: MSHA/Col; control group: HA/Col). The morphological characteristics of MSHA/Col were observed using scanning electron microscopy (SEM). Its crystal structure and chemical composition were analyzed by X-ray diffraction and Fourier transform infrared spectroscopy, respectively. The mineral phase content was evaluated by thermogravimetric analysis. The scaffold's porosity, ion release, and in vitro degradation performance were also determined. For cytological experiments, CCK-8 assay, live/dead cell staining, alkaline phosphatase staining, alizarin red S staining, RT-qPCR, and western blotting were used to evaluate the effects of the MSHA/Col scaffold on the proliferation, viability, early osteogenic differentiation activity, late mineralization capacity, and gene and protein expression levels of key osteogenic markers [runt-related transcription factor 2 (Runx2), collagen type Ⅰ (Col-Ⅰ), osteopontin (Opn), and osteocalcin (Ocn)] in mouse embryonic osteoblast precursor cells (MC3T3-E1). Results: HPAA/ACMSP appeared as amorphous spherical nanoparticles under TEM, with energy spectrum analysis showing uniform distribution of carbon, oxygen, calcium, phosphorus, magnesium, and strontium elements. SEM results of MSHA/Col indicated successful complete intrafibrillar mineralization. Elemental analysis showed the mass fractions of magnesium and strontium were 0.72% (matching the magnesium content in natural bone) and 2.89%, respectively. X-ray diffraction revealed characteristic peaks of hydroxyapatite crystals (25.86°, 31°-34°). Infrared spectroscopy results showed characteristic absorption peaks for both collagen and hydroxyapatite. Thermogravimetric analysis indicated a mineral phase content of 78.29% in the material. The scaffold porosity was 91.6% ± 1.1%, close to the level of natural bone tissue. Ion release curves demonstrated sustained release behavior for both magnesium and strontium ions. The in vitro degradation rate matched the ingrowth rate of new bone tissue. Cytological experiments showed that MSHA/Col significantly promoted MC3T3-E1 cell proliferation (130% increase in activity at 72 h, P < 0.001). MSHA/Col exhibited excellent efficacy in promoting osteogenic differentiation, significantly upregulating the expression of osteogenesis-related genes and proteins (Runx2, Col-Ⅰ, Opn, Ocn) (P < 0.01). Conclusion The MSHA/Col scaffold achieves dual biomimicry of natural bone in both composition and structure, and effectively promotes osteogenic differentiation at the genetic and protein levels, breaking through the functional limitations of pure hydroxyapatite mineralized collagen. This provides a new strategy for the development of functional bone repair materials

BACKGROUND:Bone marrow mesenchymal stem cells play a pivotal role in tissue engineering and bone regeneration.However,promoting the osteogenic differentiation of bone marrow mesenchymal stem cells poses a significant challenge.OBJECTIVE:To examine the influence of Fe3O4@ZIF-8 nanoparticles on the osteogenic differentiation of bone marrow mesenchymal stem cells under magnetic stimulation.METHODS:Zeolite imidazolate skeleton(ZIF-8)was synthesized by hydrothermal method,and magnetic Fe3O4@ZIF-8 nanoparticles were synthesized by one-pot method(2.5,5,10,and 20 μg Fe3O4 were added to the preparation materials,respectively).The Fe3O4@ZIF-8 nanoparticles were characterized by scanning electron microscopy,X-ray photoelectron spectroscopy,X-ray diffraction,and vibration sample magnetometer detection,and suitable materials were selected for subsequent experiments.Bone marrow mesenchymal stem cells of 4-week-old SD rats were extracted and co-cultured with Fe3O4@ZIF-8 nanoparticle solution with different mass concentrations(25,50,75,100,and 125 μg/mL),respectively.Cell proliferation was detected by CCK-8 assay,and the optimal material solution mass concentration was selected.After the mass concentration of the material solution was screened,magnetic stimulation was applied(magnetic field intensity was 0,50,100,and 150 MT,respectively).Cell proliferation was detected by CCK-8 assay,and the best magnetic field intensity and Fe3O4@ZIF-8 nanoparticles were selected for the experiment of induced differentiation of bone marrow mesenchymal stem cells.SD rat bone marrow mesenchymal stem cells were co-cultured with ZIF-8,Fe3O4@ZIF-8,and Fe3O4@ZIF-8(magnetic field intervention)nanoparticle solution,respectively.The single cultured cells were used as blank controls.Lipid induction was followed by oil red O staining.After osteogenesis induction,alkaline phosphatase,alizarin red staining and Runx2 protein concentration were detected.RESULTS AND CONCLUSION:(1)Under scanning electron microscopy,Fe3O4@ZIF-8 nanoparticles showed a dodecahedral structure.With the increase of Fe3O4 content in the material,the particle size of the nanoparticles increased.Fe3O4@ZIF-8 nanoparticles(5 and 10 μg Fe3O4 was added to the material preparation)with a particle size of about 250 nm(stable functional and biosafety of nanoparticles at this particle size)were selected.(2)The results of CCK-8 assay showed that 50 μg/mL Fe3O4@ZIF-8 nanoparticles(with 10 μg Fe3O4 added to the preparation of the material)could significantly promote the proliferation of bone marrow mesenchymal stem cells under a 100 MT magnetic field.The nanoparticles under this condition were selected for the osteogenic induction differentiation experiment of bone marrow mesenchymal stem cells.(3)After osteogenic induction,the alkaline phosphatase activity,extracellular matrix mineralization degree,and Runx2 protein mass concentration of bone marrow mesenchymal stem cells in Fe3O4@ZIF-8(magnetic field intervention)group were higher than those in other three groups(P<0.05).After adipogenic induction,the lipid droplet formation of bone marrow mesenchymal stem cells in Fe3O4@ZIF-8(magnetic field intervention)group was lower than that in the other three groups(P<0.05).(4)The results show that Fe3O4@ZIF-8 nanoparticles can promote osteogenic differentiation of bone marrow mesenchymal stem cells under specific magnetic field conditions.

Esophageal squamous cell carcinoma(ESCC)is a common malignant tumor with insidious early symptoms and a poor prognosis.In traditional Chinese medicine(TCM),ESCC is classified as"ye ge."Drawing on clinical experience,we believe that kidney deficiency leads to the deficiency of vital qi and immune dysfunction,providing the foundation for cancerous growth by depleting qi and damaging essence,toxic stasis and stagnation,forming a local hypoxic and acidic microenvironment that promotes tumor invasion,metastasis,and recurrence.Considering the effect of modern comprehensive treatments,the occurrence and development of ESCC are summarized as kidney deficiency being the root cause and toxic stasis being the driving force.The pathogenesis and treatment of ESCC in the preoperative,postoperative,and non-surgical treatment stages are discussed.The pathogenesis of the disease is summarized as follows:preoperatively,toxicity and stasis intertwine,depleting the kidney;postoperatively,the kidney loses its vitality,allowing various pathogenic factors to persist;during non-operative treatment,vital qi and pathogens contend,resulting in entrenched toxicity.During the preoperative neoadjuvant phase,therapy should resolve stasis,eliminate toxins,enhance kidney function,tonify essence,and support the body.During the postoperative adjuvant phase,therapy should strengthen the root and consolidate the foundation while detoxifying and expelling stasis.The non-surgical treatment stage uses"balanced interruption,"targeting tumor progression and metastasis by harmonizing yin and yang,thus preventing recurrence.This article will provide insights into the integrative Chinese-Western management of ESCC.

BACKGROUND:Bone marrow mesenchymal stem cells play a pivotal role in tissue engineering and bone regeneration.However,promoting the osteogenic differentiation of bone marrow mesenchymal stem cells poses a significant challenge.OBJECTIVE:To examine the influence of Fe3O4@ZIF-8 nanoparticles on the osteogenic differentiation of bone marrow mesenchymal stem cells under magnetic stimulation.METHODS:Zeolite imidazolate skeleton(ZIF-8)was synthesized by hydrothermal method,and magnetic Fe3O4@ZIF-8 nanoparticles were synthesized by one-pot method(2.5,5,10,and 20 μg Fe3O4 were added to the preparation materials,respectively).The Fe3O4@ZIF-8 nanoparticles were characterized by scanning electron microscopy,X-ray photoelectron spectroscopy,X-ray diffraction,and vibration sample magnetometer detection,and suitable materials were selected for subsequent experiments.Bone marrow mesenchymal stem cells of 4-week-old SD rats were extracted and co-cultured with Fe3O4@ZIF-8 nanoparticle solution with different mass concentrations(25,50,75,100,and 125 μg/mL),respectively.Cell proliferation was detected by CCK-8 assay,and the optimal material solution mass concentration was selected.After the mass concentration of the material solution was screened,magnetic stimulation was applied(magnetic field intensity was 0,50,100,and 150 MT,respectively).Cell proliferation was detected by CCK-8 assay,and the best magnetic field intensity and Fe3O4@ZIF-8 nanoparticles were selected for the experiment of induced differentiation of bone marrow mesenchymal stem cells.SD rat bone marrow mesenchymal stem cells were co-cultured with ZIF-8,Fe3O4@ZIF-8,and Fe3O4@ZIF-8(magnetic field intervention)nanoparticle solution,respectively.The single cultured cells were used as blank controls.Lipid induction was followed by oil red O staining.After osteogenesis induction,alkaline phosphatase,alizarin red staining and Runx2 protein concentration were detected.RESULTS AND CONCLUSION:(1)Under scanning electron microscopy,Fe3O4@ZIF-8 nanoparticles showed a dodecahedral structure.With the increase of Fe3O4 content in the material,the particle size of the nanoparticles increased.Fe3O4@ZIF-8 nanoparticles(5 and 10 μg Fe3O4 was added to the material preparation)with a particle size of about 250 nm(stable functional and biosafety of nanoparticles at this particle size)were selected.(2)The results of CCK-8 assay showed that 50 μg/mL Fe3O4@ZIF-8 nanoparticles(with 10 μg Fe3O4 added to the preparation of the material)could significantly promote the proliferation of bone marrow mesenchymal stem cells under a 100 MT magnetic field.The nanoparticles under this condition were selected for the osteogenic induction differentiation experiment of bone marrow mesenchymal stem cells.(3)After osteogenic induction,the alkaline phosphatase activity,extracellular matrix mineralization degree,and Runx2 protein mass concentration of bone marrow mesenchymal stem cells in Fe3O4@ZIF-8(magnetic field intervention)group were higher than those in other three groups(P<0.05).After adipogenic induction,the lipid droplet formation of bone marrow mesenchymal stem cells in Fe3O4@ZIF-8(magnetic field intervention)group was lower than that in the other three groups(P<0.05).(4)The results show that Fe3O4@ZIF-8 nanoparticles can promote osteogenic differentiation of bone marrow mesenchymal stem cells under specific magnetic field conditions.

Immunotherapy, including immune checkpoint inhibitors, tumor vaccine therapy, oncolytic virotherapy, and adoptive cell therapy, has made remarkably breakthroughs in the field of oncology. Immune checkpoint inhibitors, which block programmed death receptor 1 or programmed death ligand 1, have been included in the first-line clinical treatment for advanced solid tumors, such as non-small cell lung cancer and malignant melanoma. However, primary or secondary drug resistance in tumors severely limits the survival benefits for patients. Immune-related adverse reactions, such as pneumonia, hypothyroidism, hypophysitis, and myocarditis, also greatly affect the quality of life of patients. Fuzheng Jiedu Huayu is an important concept guiding the prevention and treatment of tumors with traditional Chinese medicine (TCM). It is also a curative principle and therapeutic TCM method to reduce the toxicity and enhance the efficacy of immunotherapy. This article summarizes the research progress of immunotherapy and discusses how TCM reduces the toxicity and enhances the efficacy of immunotherapy, hoping to provide a reference for the integrated treatment of tumors with TCM and immunotherapy.

Esophageal squamous cell carcinoma(ESCC)is a common malignant tumor with insidious early symptoms and a poor prognosis.In traditional Chinese medicine(TCM),ESCC is classified as"ye ge."Drawing on clinical experience,we believe that kidney deficiency leads to the deficiency of vital qi and immune dysfunction,providing the foundation for cancerous growth by depleting qi and damaging essence,toxic stasis and stagnation,forming a local hypoxic and acidic microenvironment that promotes tumor invasion,metastasis,and recurrence.Considering the effect of modern comprehensive treatments,the occurrence and development of ESCC are summarized as kidney deficiency being the root cause and toxic stasis being the driving force.The pathogenesis and treatment of ESCC in the preoperative,postoperative,and non-surgical treatment stages are discussed.The pathogenesis of the disease is summarized as follows:preoperatively,toxicity and stasis intertwine,depleting the kidney;postoperatively,the kidney loses its vitality,allowing various pathogenic factors to persist;during non-operative treatment,vital qi and pathogens contend,resulting in entrenched toxicity.During the preoperative neoadjuvant phase,therapy should resolve stasis,eliminate toxins,enhance kidney function,tonify essence,and support the body.During the postoperative adjuvant phase,therapy should strengthen the root and consolidate the foundation while detoxifying and expelling stasis.The non-surgical treatment stage uses"balanced interruption,"targeting tumor progression and metastasis by harmonizing yin and yang,thus preventing recurrence.This article will provide insights into the integrative Chinese-Western management of ESCC.

The success of implementation research is closely tied to the institution's pre-implementation readiness. This study aims to explore the organizational readiness for change (ORC) and its influencing factors on primary healthcare settings in the implementation of the "Shared Medical Appointment for Diabetes (SMART) in China: design of an optimization trial" and to enhance ORC and provide insights to support the effective implementation of the program.

This study aimed to localize the workplace readiness questionnaire (WRQ) and validate its applicability for assessing readiness for implementation of evidence-based practices (EBP) in primary care settings in China. The localization of the instrument will provide a practical instrument for assessing organizational readiness for change (ORC).

Objective To analyze the disease burden of early-onset colorectal cancer (EOCRC) at the global, regional, and national levels from 1990 to 2021, and to predict the disease burden trend from 2022 to 2026. Methods Based on the Global Burden of Disease (GBD) database, the incidence, mortality, and disability-adjusted life year (DALY) rate of EOCRC across 204 countries and regions from 1990 to 2021 were obtained. The time trends of these indicators were assessed by calculating the estimated annual percentage change (EAPC), and the contributions of ten risk factors to the EOCRC burden were analyzed. The autoregressive integrated moving average (ARIMA) model was used to predict the disease burden from 2022 to 2026. Results From 1990 to 2021, the number of new global EOCRC cases increased from 107 310 to 211 890, with the incidence rising from 3.96 to 5.37 per 100 000 people. In 2021, global EOCRC incidence, mortality, and DALY rate increased with age; males had higher rates than females in terms of incidence, mortality, and DALY rate in all age groups. In 2021, East Asia had the highest number of new cases, deaths, and DALY. From 1990 to 2021, the global EAPC for incidence rate was 0.96%, and death rate was –0.38%. ARIMA model indicated that from 2022 to 2026, the global incidence of EOCRC would continue to rise, while mortality and DALY rate would be expected to decline. Conclusions The disease burden of EOCRC has significantly increased globally from 1990 to 2021, with notable regional, age, and sex differences. By 2026, the mortality and DALY rate of EOCRC will decline, while the incidence is expected to further increase, highlighting the urgency of taking active measures to address the growing trend of EOCRC.

Chinese medicine therapy for removing gallstones is one of the methods for the treatment of cholelithiasis.In the view of Professor Liu Fengbin,attacking of external pathogens,improper diet and emotional disorders contribute to the main causes of cholelithiasis,and the pathogenesis of cholelithiasis is due to qi stagnation of both liver and gallbladder,and internal obstruction of damp-heat.The occurrence of cholelithiasis is closely related to deficiency of spleen and stomach,and is correlated with the pathological factors of turbid phlegm and blood stasis.For the Chinese medicine treatment of cholelithiasis,Professor Liu follows the principle of"treatment in accordance with three categories of etiological factors"(i.e,seasons,environment and body constitution).He advocates the integration of traditional Chinese medicine and western medicine,and is good at utilizing Lingnan herbs and distinctive herbs that can dissolve stones and remove stones.The treatment for cholelithiasis is mainly through the therapies of soothing liver and alleviating depression,clearing heat and removing dampness,and normalizing gallbladder function to remove stones,and is also supplemented by the therapies of invigorating spleen and replenishing qi,regulating qi to resolve phlegm,and activiting qi movement and blood circulation.Modified Da Chaihu Decoction plus Sijin Decoction is often used as a basic formula for treating cholelithiasis,which is mainly composed of Desmodii Styracifolii Herba,Galli Gigerii Endothelium Corneum,Bupleuri Radix,Curcumae Radix,Scutellariae Radix,Aucklandiae Radix,Aurantii Fructus Immaturus stir-fried with bran,Paeoniae Radix Rubra,Linderae Radix,and Rhei Radix et Rhizoma.